logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

BupivacaineCompartment syndrome following an off-label use: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2017年 / 1644卷 / 1期
关键词:
D O I:
10.1007/s40278-017-27833-2
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:61 / 61
相关论文
共 50 条
  • [41] DenosumabHypocalcaemia following off-label use: case report
    Reactions Weekly, 2022, 1923 (1) : 178 - 178
  • [42] DimeticoneGranuloma following off-label use: case report
    Reactions Weekly, 2023, 1980 (1) : 150 - 150
  • [43] NalbuphineBradycardia following an off-label use: case report
    Reactions Weekly, 2019, 1753 (1) : 255 - 255
  • [44] SildenafilHypotension following off-label use: case report
    Reactions Weekly, 2025, 2045 (1) : 376 - 376
  • [45] DaratumumabHypogammaglobulinemia following off-label use: case report
    Reactions Weekly, 2020, 1802 (1) : 114 - 114
  • [46] DapsoneMethaemoglobinaemia following off-label use: case report
    Reactions Weekly, 2021, 1843 (1) : 130 - 130
  • [47] CyproteroneMeningiomas following off-label use: case report
    Reactions Weekly, 2021, 1849 (1) : 152 - 152
  • [48] GlibenclamideHypoglycaemia following an off-label use : case report
    Reactions Weekly, 2021, 1866 (1) : 190 - 190
  • [49] SintilimabFasciitis following off-label use: case report
    Reactions Weekly, 2021, 1884 (1) : 391 - 391
  • [50] HydroxychloroquineEosinophilia following off-label use: case report
    Reactions Weekly, 2021, 1867 (1) : 204 - 204
← 12345 →